"Before Xpert I only had my expertise": A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities.
Andrew McDowellNeeraj RaizadaSunil D KhapardeRaghuram RaoSanjay SarinAakshi KalraVirender Singh SalhotraSreenivas Achuthan NairCatharina BoehmeClaudia M DenkingerPublished in: PloS one (2018)
Access to free and rapid Xpert testing for all presumptive pediatric TB patients has had multiple positive effects on pediatricians' diagnosis and treatment of TB. It has important effects on speed of diagnosis, empirical treatment, and awareness of drug resistance among TB treatment naive children. In addition, our study shows that access to public sector Xpert machines may be an important way to encourage Public-Private integration and facilitate the movement of patients from the private to public sector for anti-TB treatment. Despite availability of rapid and free Xpert testing, our study showed an alarming diversity of Xpert utilization strategies across different providers who may be moving toward suggested practice over time. The degree of diversity in TB diagnostic approaches in children reported here highlights the urgent need for concerted efforts to place Xpert early in diagnostic algorithms to positively impact the pediatric TB care pathway. A positive change in diagnostic algorithms may be possible with continued advocacy, time, and increased access.
Keyphrases
- healthcare
- mycobacterium tuberculosis
- end stage renal disease
- machine learning
- newly diagnosed
- young adults
- mental health
- prognostic factors
- peritoneal dialysis
- deep learning
- emergency department
- health insurance
- palliative care
- patient reported outcomes
- hiv infected
- combination therapy
- antiretroviral therapy
- sensitive detection